EMMAUS LIFE SCIENCES, INC.·4

May 17, 8:10 PM ET

NAGASAKI YASUSHI 4

4 · EMMAUS LIFE SCIENCES, INC. · Filed May 17, 2013

Insider Transaction Report

Form 4
Period: 2012-06-29
NAGASAKI YASUSHI
Chief Financial Officer
Transactions
  • Other

    Cnovertible Promissory Note

    2012-06-29$388800.00/sh+388,800$151,165,440,000117,818 total
    Exercise: $3.30From: 2012-06-29Common Stock (117,818 underlying)
  • Award

    Incentive Stock Options

    2013-02-28
    Exercise: $3.60Exp: 2023-02-27Common Stock
Footnotes (2)
  • [F1]The principal amount of the Convertible Promissory Note plus unpaid accrued interest (10% per annum) is convertible into shares of the Issuer's common stock. The 117,818 shares represents the number of shares into which the principal amount of the Convertible Promissory Note may be converted (the "Convertible Shares'). The note is due on demand.
  • [F2]The option vests on a cliff basis for the first one-third (1/3) granted and monthly on a prorata basis for the remaining two-thirds (2/3) thereafter in equal amounts (or as close to an equal amount as possible) over the next 24 months beginning on February 28, 2014.

Documents

1 file
  • 4
    q13-000821_nagasaki.xmlPrimary

    OWNERSHIP DOCUMENT